The role of sperm chromatin structure assay in improving the diagnosis of male factor infertility in Benin city

James A. Osaikhuwuomwan; Oseihie I. Iribhogbe; Reuben O. Iweka

doi:10.18203/2320-6012.ijrms20264160

Authors

James A. Osaikhuwuomwan Department of Obstetrics and Gynaecology, University Benin Teaching Hospital, Benin-City, Nigeria https://orcid.org/0000-0003-2553-655X
Oseihie I. Iribhogbe Department of Obstetrics and Gynaecology, University Benin Teaching Hospital, Benin-City, Nigeria https://orcid.org/0000-0003-0985-155X
Reuben O. Iweka Department of Obstetrics and Gynaecology, University Benin Teaching Hospital, Benin-City, Nigeria https://orcid.org/0009-0008-1389-3510

DOI:

https://doi.org/10.18203/2320-6012.ijrms20264160

Keywords:

DNA fragmentation index, Nigeria, Male factor infertility, Seminal fluid analysis, Sperm chromatin structure assay

Abstract

Background: Male factor infertility accounts for about 30% of infertility cases worldwide. In Nigeria, evaluation relies almost exclusively on seminal fluid analysis (SFA), which does not assess chromatin integrity; up to 15% of men with normal SFA remain sub-fertile from unrecognized chromatin abnormalities. This study aimed to determine the prevalence of abnormal sperm chromatin structure, its relationship with semen parameters, and associated risk factors among male partners of infertile couples in Benin City, using the Sperm Chromatin Structure Assay (SCSA).

Methods: In this cross-sectional study, 120 male partners of infertile couples attending the Infertility Clinic, University of Benin Teaching Hospital from April to July 2026, underwent SFA and SCSA (flow cytometry with acridine orange staining) to determine the DNA Fragmentation Index (DFI). Data were analysed using descriptive statistics, correlation, and logistic regression; p<0.05 was significant.

Results: Mean age was 45.3±8.0 years and mean DFI was 22.4±7.1%. Abnormal DFI (>25%) occurred in 39.2% (95% CI 30.9-48.1%) of participants. DFI correlated negatively with motility, progressive motility, morphology, and vitality (all p<0.05), but not with volume or sperm count. Notably, 21.3% of men with normal SFA had abnormal DFI. Cigarette smoking was the only independent predictor of abnormal DFI (adjusted OR 3.57, p=0.002); no seminal parameter achieved acceptable diagnostic accuracy (AUC≥0.70) as a DFI proxy.

Conclusions: Abnormal sperm chromatin structure is common among Nigerian men with infertility and is incompletely captured by semen analysis alone. SCSA should be incorporated into male infertility evaluation, particularly for semen with low vitality or progressive motility. Also, instructive to prioritize smoking cessation counselling as a modifiable risk factor.

References

Huang B, Wang Z, Kong Y, Jin M, Ma L. Global, regional and national burden of male infertility in 204 countries and territories between 1990 and 2019: an analysis of global burden of disease study. BMC Public Health. 2023;23(1):2195.

Mazzilli R, Rucci C, Vaiarelli A, Cimadomo D, Ubaldi FM, Foresta C, et al. Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes. J Endocrinol Invest. 2023;46(6):1079-85.

Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015;13(1):37.

Pourmasumi S, Nazari A, Fagheirelahee N, Sabeti P. Cytochemical tests to investigate sperm DNA damage: assessment and review. J Family Med Prim Care. 2019;8(5):1533-9.

Coughlan C, Clarke H, Cutting R, Saxton J, Waite S, Ledger W, et al. Sperm DNA fragmentation, recurrent implantation failure and recurrent miscarriage. Asian J Androl. 2015;17(4):681-5.

Gu LJ, Chen ZW, Chen ZJ, Xu JF, Li M. Sperm chromatin anomalies have an adverse effect on the outcome of conventional in vitro fertilization: a study with strictly controlled external factors. Fertil Steril. 2009;92(4):1344-6.

Evenson DP. The Sperm Chromatin Structure Assay (SCSA®) and other sperm DNA fragmentation tests for evaluation of sperm nuclear DNA integrity as related to fertility. Anim Reprod Sci. 2016;169:56-75.

Tanga BM, Qamar AY, Raza S, Bang S, Fang X, Yoon K, et al. Semen evaluation: methodological advancements in sperm quality-specific fertility assessment-a review. Anim Biosci. 2021;34(8):1253-70.

Oleszczuk K, Augustinsson L, Bayat N, Giwercman A, Bungum M. Prevalence of high DNA fragmentation index in male partners of unexplained infertile couples. Andrology. 2013;1(3):357-60.

Ghuman NK, Shukla KK, Nandagopal S, Raikar S, Kumar S, Kathuria P, et al. Explaining the unexplained: examining the predictive value of semen parameters, sperm DNA fragmentation and metal levels in unexplained infertility. J Hum Reprod Sci. 2023;16(4):317-23.

Faduola P, Kolade CO. Sperm chromatin structure assay results in Nigerian men with unexplained infertility. Clin Exp Reprod Med. 2015;42(3):101-5.

Ibitoye BO, Bashir FO, Ibitoye FO, Alabi O, Olaniyan OT, Faduola P, et al. Pattern and value of sperm DNA fragmentation index and its correlation with spermiogram in infertile South West Nigerian men. Morphologie. 2024;108(361):100763.

Sills ES, Fryman JT, Perloe M, Michels KB, Tucker MJ. Chromatin fluorescence characteristics and standard semen analysis parameters: correlations observed in andrology testing among 136 males referred for infertility evaluation. J Obstet Gynaecol. 2004;24(1):74-7.

Yang T, Yu L, Xu J, Ying L, Jia Y, Zheng Y, et al. Correlation between standard sperm parameters and sperm DNA fragmentation from 11,339 samples. Syst Biol Reprod Med. 2024;70(1):91-100.

Fan L, Hu JQ, Wen Y, Chen YY, Luo M, Liu ZH. [Correlation of sperm HDS with sperm DFI and morphology and its influence on in vitro fertilization in infertile males]. Zhonghua Nan Ke Xue. 2023;29(4):317-22.

Esteves SC, Agarwal A, Majzoub A. An evidence-based perspective on the role of sperm chromatin integrity and sperm DNA fragmentation testing in male infertility. Transl Androl Urol. 2017;6(Suppl 4):S665-72.

Evenson DP. Evaluation of sperm chromatin structure and DNA strand breaks is an important part of clinical male fertility assessment. Transl Androl Urol. 2017;6(Suppl 4):S495-500.

Oleszczuk K, Giwercman A, Bungum M. Sperm chromatin structure assay in prediction of in vitro fertilization outcome. Andrology. 2016;4(2):290-6.

Tavalaee M, Razavi S, Nasr-Esfahani MH. Influence of sperm chromatin anomalies on assisted reproductive technology outcome. Fertil Steril. 2009;91(4):1119-26.

Li Z, Wang L, Cai J, Huang H. Correlation of sperm DNA damage with IVF and ICSI outcomes: a systematic review and meta-analysis. J Assist Reprod Genet. 2006;23(9-10):367-76.

Ribas-Maynou J, Yeste M, Becerra-Tomás N, Aston KI, James ER, Salas-Huetos A. Clinical implications of sperm DNA damage in IVF and ICSI: updated systematic review and meta-analysis. Biol Rev Camb Philos Soc. 2021;96(4):1284-300.

Esbert M, Pacheco A, Soares SR, Amorós D, Florensa M, Ballesteros A, et al. High sperm DNA fragmentation delays human embryo kinetics when oocytes from young and healthy donors are microinjected. Andrology. 2018;6(5):697-706.

Marinaro JA, Schlegel PN. Sperm DNA damage and its relevance in fertility treatment: a review of recent literature and current practice guidelines. Int J Mol Sci. 2023;24(2):1446.

Aydos K, Aydos OS. Sperm selection procedures for optimizing the outcome of ICSI in patients with NOA. J Clin Med. 2021;10(12):2687.

Cano-Extremera M, Hervas I, Gisbert Iranzo A, Falquet Guillem M, Gil Juliá M, Navarro-Gomezlechon A, et al. Superior live birth rates, reducing sperm DNA fragmentation (SDF), and lowering miscarriage rates by using testicular sperm versus ejaculates in intracytoplasmic sperm injection (ICSI) cycles from couples with high SDF: a systematic review and meta-analysis. Biology (Basel). 2025;14(2):130.

Duffy JMN, Bhattacharya S, Bofill M, Collura B, Curtis C, Evers JLH, et al. Standardising definitions and reporting guidelines for the infertility core outcome set: an international consensus development study. Hum Reprod. 2020;35(12):2735-45.

European Society of Human Reproduction and Embryology (ESHRE). Good clinical treatment in assisted reproduction-an ESHRE position paper. ESHRE Monogr. 2008.

Cochran WG. Sampling Techniques. 3rd ed. New York: John Wiley & Sons; 1977:149-56.

Castilla JA, Zamora S, Gonzalvo MC, Luna del Castillo JD, Roldan-Nofuentes JA, Clavero A, et al. Sperm chromatin structure assay and classical semen parameters: systematic review. Reprod Biomed Online. 2010;20(1):114-24.

Sepaniak S, Forges T, Gerard H, Foliguet B, Bene MC, Monnier-Barbarino P. The influence of cigarette smoking on human sperm quality and DNA fragmentation. Toxicol. 2006;223(1-2):54-60.

Szabó A, Váncsa S, Hegyi P, Váradi A, Forintos A, Filipov T, et al. Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):5.

Osadchuk L, Kleshchev M, Osadchuk A. Effects of cigarette smoking on semen quality, reproductive hormone levels, metabolic profile, zinc and sperm DNA fragmentation in men: results from a population-based study. Front Endocrinol (Lausanne). 2023;14:1255304.